BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel treatment in patients with advanced gastric cancer
この論文をさがす
収録刊行物
-
- Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association / International Gastric Cancer Association, Japanese Gastric Cancer Association [編]
-
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association / International Gastric Cancer Association, Japanese Gastric Cancer Association [編] 19 (3), 827-838, 2016
Tokyo : Springer Japan
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1523669554784074240
-
- NII論文ID
- 40020881713
-
- NII書誌ID
- AA11316227
-
- ISSN
- 14363291
-
- NDL書誌ID
- 027487495
-
- 本文言語コード
- en
-
- NDL 雑誌分類
-
- ZS34(科学技術--医学--腫瘍・癌)
-
- データソース種別
-
- NDL
- CiNii Articles